Evolv completes restatement, reports Q4 revenue $29.1M (+41% YoY) and positive adjusted EBITDA $0.4M

Evolv Technologies Holdings, Inc.

2025-Q1 EPS reported -$0.01 revenue$32,007,000

Restatement corrects $3.1M net revenue recognition errors from Q2'22 to Q2'24; company regains SEC and Nasdaq compliance.
Q4'24 revenue $29.1M (+41% YoY); ARR $99.4M (+39% YoY); RPO $266.7M.
Q4'24 adjusted EBITDA $0.4M vs $(10.3)M in Q4'23; net loss $(15.7)M ($0.10/share).
Full year 2024 revenue $103.9M (+31% YoY); net loss $(54.0)M ($0.34/share).
Cash $51.9M, no debt; ~6,100 units deployed (adjusted to remove ~100 non-revenue generating units).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.